Effects of lysophosphatidic acid receptor 1 (LPA1) antagonism on biomarkers in patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF): data from a randomized phase 2 trial with BMS-986278

被引：1
|
作者：
Maher, Toby M. [1 ]
Kaminski, Naftali [2 ]
Wang, Fang [3 ]
Yarra, Tejaswi [3 ]
Elpers, Brandon [3 ]
Hu, Sarah [3 ]
Schafer, Peter [3 ]
Horan, Gerald [3 ]
机构：
[1] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[2] Yale Univ, Sch Med, Pulm Crit Care & Sleep Med, New Haven, CT USA
[3] Bristol Myers Squibb, Princeton, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.OA2860
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 33 条
  • [1] BMS-986278, an Oral Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist, for Patients With Idiopathic Pulmonary Fibrosis: Results From a Phase 2 Randomized Trial
    Corte, T. J.
    Cottin, V.
    Glassberg, M. K.
    Kreuter, M.
    Ogura, T.
    Suda, T.
    Goldin, J. G.
    Berkowitz, E.
    Elpers, B.
    Kim, S.
    Tirucherai, G. S.
    Watanabe, H.
    Fischer, A.
    Maher, T. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [2] Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)
    Corte, Tamera J.
    Lancaster, Lisa
    Swigris, Jeffrey J.
    Maher, Toby M.
    Goldin, Jonathan G.
    Palmer, Scott M.
    Suda, Takafumi
    Ogura, Takashi
    Minnich, Anne
    Zhan, Xiaojiang
    Tirucherai, Giridhar S.
    Elpers, Brandon
    Xiao, Hong
    Watanabe, Hideaki
    Smith, R. Adam
    Charles, Edgar D.
    Fischer, Aryeh
    BMJ OPEN RESPIRATORY RESEARCH, 2021, 8 (01)
  • [3] RCT Abstract - BMS-986278 for progressive pulmonary fibrosis (PPF): results from a phase 2 randomized controlled trial
    Corte, Tamera
    Behr, Jueergen
    Cottin, Vincent
    Glassberg, Marilyn K.
    Kreuter, Michael
    Martinez, Fernando
    Ogura, Takashi
    Suda, Takafumi
    Wijsenbeek, Marlies
    Elpers, Brandon
    Kim, Sinae
    Watanabe, Hideaki
    Fischer, Aryeh
    Maher, Toby M.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [4] BMS-986278, an LPA1 Receptor Antagonist for Idiopathic Pulmonary Fibrosis: Preclinical Assessments of Potential Hepatobiliary Toxicity
    Gill, M. W.
    Lakshmi, S.
    Cheng, P. T. W.
    Murphy, B. J.
    Chadwick, K.
    Lehman-McKeeman, L.
    Graziano, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [5] LPA1 antagonist BMS-986278 for idiopathic pulmonary fibrosis: Preclinical pharmacological in vitro and in vivo evaluation
    Murphy, Brian
    Sum, Chi-Shing
    Wang, Tao
    Heiry, Rebekah
    Kalinowski, Stephen
    Hung, Chen-Pin
    Chu, Ching-Hsuen
    Azzara, Anthony
    Milinda, Ziegler
    Burns, Lisa
    Zinker, Bradley
    Boehm, Stephanie
    Taylor, Joseph
    Sapuppo, Julia
    Kathy, Mosure
    Mary-Ellen, Cvijic
    Kaltenbach, Robert
    Dhanusu, Suresh
    Tao, Shiwei
    Zhang, Hao
    Kennedy, Larry
    Shi, Jun
    Li, Jun
    Walker, Steve
    Shi, Yan
    Wang, Ying
    Reddigunta, Ramesh
    Jeffrey, Roble
    Ellsworth, Bruce
    Gordon, David
    Soars, Matt
    Gill, Michael
    Cheng, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [6] Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases
    Cheng, Peter T. W.
    Kaltenbach, Robert F.
    Zhang, Hao
    Shi, Jun
    Tao, Shiwei
    Li, Jun
    Kennedy, Lawrence J.
    Walker, Steven J.
    Shi, Yan
    Wang, Ying
    Dhanusu, Suresh
    Reddigunta, Ramesh
    Kumaravel, Selvakumar
    Jusuf, Sutjano
    Smith, Daniel
    Krishnananthan, Subramaniam
    Li, Jianqing
    Wang, Tao
    Heiry, Rebekah
    Sum, Chi Shing
    Kalinowski, Stephen S.
    Hung, Chen-Pin
    Chu, Ching-Hsuen
    Azzara, Anthony, V
    Ziegler, Milinda
    Burns, Lisa
    Zinker, Bradley A.
    Boehm, Stephanie
    Taylor, Joseph
    Sapuppo, Julia
    Mosure, Kathy
    Everlof, Gerry
    Guarino, Victor
    Zhang, Lisa
    Yang, Yanou
    Ruan, Qian
    Xu, Carrie
    Apedo, Atsu
    Traeger, Sarah C.
    Cvijic, Mary Ellen
    Lentz, Kimberley A.
    Tirucherai, Giridhar
    Sivaraman, Lakshmi
    Robl, Jeffrey
    Ellsworth, Bruce A.
    Rosen, Glenn
    Gordon, David A.
    Soars, Matthew G.
    Gill, Michael
    Murphy, Brian J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (21) : 15549 - 15581
  • [7] Effect of BMS-986278, An Oral LPA1 Antagonist, on Time to Disease Progression in Patients With Pulmonary Fibrosis: A Post Hoc Analysis of Data From a Phase 2 Randomized Trial
    Kreuter, M.
    Maher, T. M.
    Wuyts, W. A.
    Valenzuela, C.
    Hamblin, M. J.
    Kim, S.
    Patel, A.
    Elpers, B.
    Richeldi, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [8] Mechanism of hepatobiliary toxicity of the LPA1 antagonist BMS-986020 developed to treat idiopathic pulmonary fibrosis: Contrasts with BMS-986234 and BMS-986278
    Gill, Michael W.
    Murphy, Brian J.
    Cheng, Peter T. W.
    Sivaraman, Lakshmi
    Davis, Myrtle
    Lehman-McKeeman, Lois
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2022, 438
  • [9] Idiopathic Pulmonary Fibrosis (ipf): Development Of A Potential Lysophosphatidic Acid Receptor 1 (lpa1) Pet Tracer For Lung Receptor Occupancy Imaging
    Du, S.
    Donnelly, D. J.
    Pena, A.
    Kim, J.
    Nabulsi, N.
    Gallezot, J. -D.
    Huang, Y.
    Carson, R. E.
    Bonacorsi, S.
    Hayes, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [10] BMS-986278, a lysophosphatidic acid 1 (LPA1) receptor antagonist, in healthy participants: A single/multiple ascending dose (SAD/MAD) phase 1 study
    Tirucherai, Giridhar
    Yu, Dale
    Revankar, Ratna
    Klinger, George
    Van Lier, Jan Jaap
    Taubel, Jorg
    Correll, Todd
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
1234